Biospecifics technologies corp (BSTC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net income

24,552

24,469

23,299

22,069

20,491

20,053

16,514

14,185

11,962

11,328

11,600

11,939

11,887

11,372

11,113

10,931

10,115

9,617

8,878

7,402

6,222

4,645

4,452

4,236

4,686

5,285

4,661

3,953

3,591

2,981

1,951

1,750

3,652

6,601

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

132

314

651

1,214

1,936

2,432

2,591

2,524

2,394

2,239

2,108

1,960

1,821

1,691

1,501

1,429

1,175

933

697

458

374

247

0

0

0

-

-

67

67

64

61

58

53

50

0

0

0

Stock-based compensation expense

1,220

861

623

427

372

263

186

156

126

127

133

133

133

133

133

133

133

105

77

49

21

21

21

16

90

111

133

158

215

228

328

428

423

517

0

0

0

Deferred tax expense (credit)

-86

-175

0

0

0

-

-

-

-

-1,550

-378

-286

-249

2,667

2,733

2,520

2,362

-455

-847

-638

-423

-429

-11

-19

24

10

-855

-1,059

-1,233

-1,474

-622

-472

-751

3,047

0

0

0

Amount of amortization expense for right-of-use asset from operating lease.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Accretion) amortization of bond (discount) premium

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on the sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

1

0

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

1,274

2,547

3,313

3,081

-2,688

4,308

2,218

1,430

6,682

844

835

383

1,141

1,262

-365

1,277

130

-390

1,146

971

1,738

-2,051

-1,964

-1,858

-978

-77

1,839

1,083

1,062

1,845

1,505

1,943

831

1,250

0

0

0

Income tax payable

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax payable

0

-

-

-

0

-

-

-

-

-563

56

-594

-646

-422

-1,174

176

289

263

423

-564

345

397

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

433

319

34

175

23

23

128

36

-2

-0

118

69

116

240

159

142

163

124

0

0

0

-

-

-

-

176

456

385

196

51

-268

-66

146

65

0

0

0

Investment interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Patent costs

238

226

215

134

76

121

299

283

249

204

0

12

17

23

25

19

31

25

37

64

47

198

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-318

-802

-239

-939

163

325

-207

-51

80

195

-206

575

523

127

340

-243

-145

67

133

112

-93

-90

-81

58

111

121

-17

64

-1,668

-88

-161

-1,124

-728

-3,009

0

0

0

The increase (decrease) during the reporting period in the carrying amount lease obligations.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-139

-430

-701

-943

-1,198

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,754

8,028

8,300

50

-49

-49

-54

-59

-64

-78

-105

-133

-161

-243

-308

-372

-437

-437

-437

-483

0

0

0

Net cash provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,001

-

8,390

7,254

4,191

6,129

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

24,465

22,285

19,994

19,476

24,646

17,730

16,059

14,941

8,962

13,157

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

1,129

-627

2,737

-687

0

0

0

Cash flows from investing activities:
Purchases of property and equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable investments

108,180

93,068

93,426

80,343

75,036

75,170

69,121

58,744

56,390

54,320

54,273

54,395

49,226

43,242

35,575

27,470

21,106

14,070

12,674

11,137

10,637

7,646

7,935

10,091

8,716

9,710

7,860

7,500

6,270

5,070

5,000

7,360

7,360

5,360

0

0

0

Purchases of marketable investments

132,331

125,102

115,368

99,136

94,140

86,629

78,372

67,614

61,700

64,687

63,300

68,670

62,070

59,935

57,326

46,180

42,005

34,180

30,427

24,143

16,978

12,848

9,003

9,918

11,727

11,556

9,396

10,466

6,232

5,190

5,190

7,000

7,000

5,000

0

0

0

Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

1

0

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-20,899

-

-17,752

-13,006

-6,341

-5,200

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment for royalty buy down

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,500

1,500

1,500

0

0

0

0

Net cash provided by (used in) investing activities

-24,220

-32,033

-21,941

-18,793

-19,104

-11,458

-9,250

-8,870

-5,310

-10,366

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-1,690

-1,139

-1,139

360

0

0

0

Cash flows from financing activities:
Proceeds from stock option exercises

2,133

2,191

2,133

3,447

2,496

2,570

2,708

997

269

395

440

792

792

711

539

1,328

2,964

2,823

4,756

3,650

2,117

2,146

224

199

96

30

10

70

70

148

148

88

160

82

0

0

0

Payments for repurchase of common stock

841

620

0

0

0

-

-

-

-

616

767

834

871

1,048

1,518

1,794

2,087

1,802

1,261

780

862

829

817

1,028

549

674

968

945

1,041

1,034

1,053

1,019

938

739

0

0

0

Excess tax benefits from share-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

302

843

2,049

2,801

3,808

3,643

2,587

2,693

1,939

0

0

0

-

-

-

-

262

1,493

1,465

1,811

1,709

0

0

0

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,678

-

7,138

5,458

3,948

3,257

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

1,291

1,571

1,334

328

-503

-429

149

859

-124

-220

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

588

534

1,033

1,052

0

0

0

Increase in cash and cash equivalents

1,536

-8,177

-611

1,012

5,038

5,842

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

2,570

1,674

-934

-482

-374

-2,740

-1,582

-1,219

-4,672

-2,223

-293

1,799

4,185

5,104

4,823

1,686

2,241

783

229

1,470

186

28

-1,232

2,632

725

0

0

0

Cash paid during the year for [Abstract]
Interest

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Taxes

5,301

5,292

5,962

4,626

5,424

5,417

4,907

5,247

3,940

5,400

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5,906

-

546

80

480

415

1,350

2,240

2,350

2,713

1,848

1,028

610

232

162

282

190

190

0

0

0